IRVINE, Calif., Aug. 22, 2011 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the global leader in medical aesthetic devices, kicks off the rock of all ages tour with the introduction of The I Wanna Be Sublated, Road to Rejuvenation World Tour – a consumer awareness campaign developed to inspire and revolutionize the landscape of anti-aging with a novel, non-surgical, treatment category in facial rejuvenation - Sublative®. "Sublative rejuvenation is the byproduct of countless product development discussions with the brightest minds in Dermatology and Plastic Surgery," said Louis P. Scafuri, Chief Executive Officer of Syneron. "The driving topic remains centered on what we can do to meet the needs of our customers' patient base and inspire exciting and innovative advancements in our field. Physicians and patients have come to agree that Sublative is the answer to both points."
At first glance the Sublative treatment is already sparking new light for future aesthetic applications as the world's first treatment powered solely by fractionated, bi-polar radio-frequency. "Syneron's expertise as an innovator of radio-frequency technology spans over a decade," said James Bartholomeusz, Global Vice President of Product Development of Syneron. "Our Sublative technology is the latest evolution to captivate the facial rejuvenation world with a novel treatment that transcends through all skin types and age groups. Its versatility amplified with effectiveness positions Sublative as the ideal treatment for the modern-day patient on the go."
Safe and effective for all skin types and age groups, experts will agree that Sublative stands alone in energy-based facial cosmetic applications due to its unique energy delivery model. "To achieve the best possible results when addressing skin imperfections it is essential that the energy reaches below the skin without overheating the top layer of the skin," said Dr. Doris Day, M.D., board-certified Dermatologist at My Clear Skin Day Dermatology and Aesthetics in Manhattan, New York. "Sublative finally provides me with a proven solution to this long-known theory and opens up an option for a much wider patient base in my practice." "For my patients that are looking to rejuvenate their overall complexion without significant downtime, Sublative has been a nice addition to our practice," said Jason Diamond, M.D. board-certified Facial Plastic and Reconstructive Surgeon at The Diamond Face Institute in Beverly Hills, California and featured star on the hit show Dr. 90210.
The coast-to-coast tour is scheduled to reach major cities like Los Angeles and New York in addition to other metropolitan cities such as Phoenix, Denver, Miami, Tampa, San Francisco, San Diego and Chicago. The tour will consist of a variety of different educational events such as open houses, gifting suites and press events. Exclusive Backstage Passes that provide direct access to some of the world-renowned Dermatologists and Plastic Surgeons for a first-hand experience to be Sublated are available for interested media personnel.For more information about obtaining the Exclusive I Wanna Be Sublated Backstage Pass contact firstname.lastname@example.org or follow our tour updates by liking us on Facebook (Sublative) or following us on Twitter (@sublative). To locate a local treatment provider also visit www.sublativeskin.com. About Syneron Medical Ltd. Syneron Medical Ltd. – a company devoted to real technology, real science and real results – is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. The Company's aspiration and commitment to innovation expands Syneron's offering beyond medical devices into the largest in-demand applications in beauty - skin lightening. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide. Additional information can be found at www.syneron.com. SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS